Application value of systemic immune-inflammation index in predicting severe Mycoplasma pneumoniae pneumonia
PLOS One · 09.10.2025 · 20 (10) · e0333267
DOI: 10.1371/journal.pone.0333267 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 09.10.2025. Verfasst von Xiaocong Guo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China. Hauptthemen laut MEDLINE: Pneumonia, Mycoplasma, Inflammation, Mycoplasma pneumoniae. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ZiGong Science and Technology Bureau.
Abstract (Originalsprache)
Mycoplasma pneumoniae (MP) is the primary causative agent of community-acquired pneumonia. Severe mycoplasma pneumoniae pneumonia (SMPP) can result in multiorgan damage and even respiratory failure or death. This study aimed to evaluate the predictive value of the Systemic Immune-Inflammation Index (SII) for SMPP. This retrospective study included 254 hospitalized children with MP infections (SMPP group, n = 103; non-SMPP group, n = 151). Patient data, including complete blood count parameters (white blood cell, absolute neutrophil, absolute lymphocyte, absolute monocyte, and platelet counts), C-reactive protein (CRP), serum amyloid A (SAA), and other markers, were collected. Furthermore, the SII, Systemic Inflammation Response Index (SIRI), neutrophil/lymphocyte ratio (NLR), monocyte/lymphocyte ratio (MLR), and platelet/lymphocyte ratio (PLR) were calculated. T -tests and the Mann–Whitney U test were used to analyze differences between the groups. Logistic regression was applied to analyze the risk factors. Receiver operating characteristic (ROC) curves were plotted to evaluate the predictive performance of the SII and CRP for SMPP. The SMPP group exhibited significantly higher CRP and SAA levels, SII, NLR, MLR, PLR, and SIRI than the non-SMPP group (all P < 0.001). Logistic regression revealed that the SII (odds ratio [OR] = 1.006, 95% confidence interval [CI]: 1.001–1.010) and CRP (OR = 1.080, 95% CI: 1.041–1.120) were independent risk factors. ROC curve of the SII (area under the ROC curve = 0.883, sensitivity = 0.699, and specificity = 0.881) outperformed that of CRP. Thus, SII can serve as an effective biomarker for SMPP prediction. It can be a rapid and cost-effective method when combined with routine blood tests, thereby demonstrating considerable potential for clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China.
- Department of Laboratory Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
- Department of Clinical Laboratory, Zigong First People's Hospital, Zigong, China.
- Department of Neurology, Zigong First People's Hospital, Zigong, China.
ORCID-Profile: Xiaocong Guo, Xiaoya Xu
Förderung
- ZiGong Science and Technology Bureau
Zitieren
APA
Guo, X., Luo, H., Song, Y., Xiao, L., Xu, X., & Guo, Y. (2025). Application value of systemic immune-inflammation index in predicting severe Mycoplasma pneumoniae pneumonia. PLOS One, 20(10), e0333267. https://doi.org/10.1371/journal.pone.0333267
Vancouver
Guo X, Luo H, Song Y, Xiao L, Xu X, Guo Y. Application value of systemic immune-inflammation index in predicting severe Mycoplasma pneumoniae pneumonia. PLOS One. 2025;20(10):e0333267. doi:10.1371/journal.pone.0333267
BibTeX
@article{Guo2025,
author = {Guo, Xiaocong and Luo, Honglin and Song, Yaohui and Xiao, Li and Xu, Xiaoya and Guo, Yongcan},
title = {Application value of systemic immune-inflammation index in predicting severe Mycoplasma pneumoniae pneumonia},
journal = {PLOS One},
year = {2025},
volume = {20},
number = {10},
pages = {e0333267},
doi = {10.1371/journal.pone.0333267}
}
EUVIMED